相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Human antimicrobial peptides and cancer
Ge Jin et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2019)
In vitro activities of antimicrobial peptides and ceragenins against Legionella pneumophila
A. Seher Birteksoz-Tan et al.
JOURNAL OF ANTIBIOTICS (2019)
Inhibition of inflammatory response in human keratinocytes by magnetic nanoparticles functionalized with PBP10 peptide derived from the PIP2-binding site of human plasma gelsolin
Ewelina Piktel et al.
JOURNAL OF NANOBIOTECHNOLOGY (2019)
Use of ceragenins as a potential treatment for urinary tract infections
Urszula Wnorowska et al.
BMC INFECTIOUS DISEASES (2019)
Preclinical testing of a broad-spectrum antimicrobial endotracheal tube coated with an innate immune synthetic mimic
Marjan M. Hashemi et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Investigation of the in vitro antifungal and antibiofilm activities of ceragenins CSA-8, CSA-13, CSA-44, CSA-131, and CSA-138 against Candida species
Cagla Bozkurt-Guzel et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2018)
Ceragenin CSA13 Reduces Clostridium difficile Infection in Mice by Modulating the Intestinal Microbiome and Metabolites
Jiani Wang et al.
GASTROENTEROLOGY (2018)
Enhanced antimicrobial activity of naturally derived bioactive molecule chitosan conjugated silver nanoparticle against dental implant pathogens
Darshan Devang Divakar et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
Ceragenins are active against drug-resistant Candida auris clinical isolates in planktonic and biofilm forms
Marjan M. Hashemi et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
A comparison of methods to assess the antimicrobial activity of nanoparticle combinations on bacterial cells
Claire Bankier et al.
PLOS ONE (2018)
Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations
Jaison Jeevanandam et al.
BEILSTEIN JOURNAL OF NANOTECHNOLOGY (2018)
Ceragenin CSA-13 as free molecules and attached to magnetic nanoparticle surfaces induce caspase-dependent apoptosis in human breast cancer cells via disruption of cell oxidative balance
Ewelina Piktel et al.
Oncotarget (2018)
Nanoparticles and their antimicrobial properties against pathogens including bacteria, fungi, parasites and viruses
Arezou Khezerlou et al.
MICROBIAL PATHOGENESIS (2018)
Nano based drug delivery systems: recent developments and future prospects
Jayanta Kumar Patra et al.
JOURNAL OF NANOBIOTECHNOLOGY (2018)
Comparative in vitro antimicrobial activities of CSA-142 and CSA-192, second-generation ceragenins, with CSA-13 against various microorganisms
Cagla Bozkurt Guzel et al.
JOURNAL OF CHEMOTHERAPY (2018)
Cathelicidins: Immunomodulatory Antimicrobials
Roel M. van Harten et al.
VACCINES (2018)
Scolopendin, an antimicrobial peptide from centipede, attenuates mitochondrial functions and triggers apoptosis in Candida albicans
Heejeong Lee et al.
BIOCHEMICAL JOURNAL (2017)
Use of magnetic nanoparticles as a drug delivery system to improve chlorhexidine antimicrobial activity
Grazyna Tokajuk et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Antibacterial properties and toxicity from metallic nanomaterials
Gina V. Vimbela et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Nanomaterials for alternative antibacterial therapy
Hassan A. Hemeg
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
The antimicrobial activity of nanoparticles: present situation and prospects for the future
Linlin Wang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Enhancing the fungicidal activity of antibiotics: are magnetic nanoparticles the key?
Katarzyna Niemirowicz et al.
NANOMEDICINE (2017)
Development of antifungal therapies using nanomaterials
Katarzyna Niemirowicz et al.
NANOMEDICINE (2017)
CSA13 inhibits colitis-associated intestinal fibrosis via a formyl peptide receptor like-1 mediated HMG-CoA reductase pathway
Chunlan Xu et al.
SCIENTIFIC REPORTS (2017)
Metal nanoparticles: understanding the mechanisms behind antibacterial activity
Yael N. Slavin et al.
JOURNAL OF NANOBIOTECHNOLOGY (2017)
Peptides with Dual Antimicrobial and Anticancer Activities
Mario R. Felicio et al.
FRONTIERS IN CHEMISTRY (2017)
Sporicidal activity of ceragenin CSA-13 against Bacillus subtilis
Ewelina Piktel et al.
SCIENTIFIC REPORTS (2017)
Formulation and candidacidal activity of magnetic nanoparticles coated with cathelicidin LL-37 and ceragenin CSA-13
Katarzyna Niemirowicz et al.
SCIENTIFIC REPORTS (2017)
Effect of Iron Oxide Nanoparticles and Amoxicillin on Bacterial Growth in the Presence of Dissolved Organic Carbon
Kelley M. Current et al.
BIOMEDICINES (2017)
Synthetic antimicrobial peptides of the halictines family disturb the membrane integrity of Candida cells
Marie Kodedova et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2017)
Anaerobic bacteria growth in the presence of cathelicidin LL-37 and selected ceragenins delivered as magnetic nanoparticles cargo
Bonita Durnas et al.
BMC MICROBIOLOGY (2017)
Beyond conventional antibiotics - New directions for combination products to combat biofilm
Danir Fanisovich Bayramov et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
miR-663a regulates growth of colon cancer cells, after administration of antimicrobial peptides, by targeting CXCR4-p21 pathway
Kengo Kuroda et al.
BMC CANCER (2017)
The Role of Cathelicidin LL-37 in Cancer Development
Ewelina Piktel et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2016)
Targeted iron oxide nanoparticles for the enhancement of radiation therapy
Anastasia K. Hauser et al.
BIOMATERIALS (2016)
Antitumor effects of cecropin B-LHRH' on drug-resistant ovarian and endometrial cancer cells
Xiaoyong Li et al.
BMC CANCER (2016)
Antimicrobial peptides and wound healing: biological and therapeutic considerations
Maria Luisa Mangoni et al.
EXPERIMENTAL DERMATOLOGY (2016)
Antimicrobial peptides (AMPs) as drug candidates: a patent review (2003-2015)
Paulina Kosikowska et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2016)
Core-shell magnetic nanoparticles display synergistic antibacterial effects against Pseudomonas aeruginosa and Staphylococcus aureus when combined with cathelicidin LL-37 or selected ceragenins
Katarzyna Niemirowicz et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
Magnetic nanoparticles as a drug delivery system that enhance fungicidal activity of polyene antibiotics
Katarzyna Niemirowicz et al.
Nanomedicine-Nanotechnology Biology and Medicine (2016)
Cationic Antimicrobial Peptides Derived from Crocodylus siamensis Leukocyte Extract, Revealing Anticancer Activity and Apoptotic Induction on Human Cervical Cancer Cells
Tinnakorn Theansungnoen et al.
PROTEIN JOURNAL (2016)
The oncolytic peptide LTX-315 triggers immunogenic cell death
H. Zhou et al.
CELL DEATH & DISEASE (2016)
Antimicrobial Peptides : An Emerging Category of Therapeutic Agents
Margit Mahlapuu et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2016)
Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy
Ewelina Piktel et al.
JOURNAL OF NANOBIOTECHNOLOGY (2016)
Candidacidal Activity of Selected Ceragenins and Human Cathelicidin LL-37 in Experimental Settings Mimicking Infection Sites
Bonita Durnas et al.
PLOS ONE (2016)
DRAMP: a comprehensive data repository of antimicrobial peptides
Linlin Fan et al.
SCIENTIFIC REPORTS (2016)
Bactericidal Activities of Cathelicidin LL-37 and Select Cationic Lipids against the Hypervirulent Pseudomonas aeruginosa Strain LESB58
Urszula Wnorowska et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Bactericidal Activity of Ceragenin CSA-13 in Cell Culture and in an Animal Model of Peritoneal Infection
Robert Bucki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Understanding bacterial resistance to antimicrobial peptides: From the surface to deep inside
Simone Maria-Neto et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2015)
Inactivation of the Antifungal and Immunomodulatory Properties of Human Cathelicidin LL-37 by Aspartic Proteases Produced by the Pathogenic Yeast Candida albicans
Maria Rapala-Kozik et al.
INFECTION AND IMMUNITY (2015)
Magnetically stimulated ciprofloxacin release from polymeric microspheres entrapping iron oxide nanoparticles
Sirinrath Sirivisoot et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2015)
Photothermal killing of Staphylococcus aureus using antibody-targeted gold nanoparticles
Nancy J. Millenbaugh et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2015)
Magnetic nanoparticles enhance the anticancer activity of cathelicidin LL-37 peptide against colon cancer cells
Katarzyna Niemirowicz et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2015)
Local Delivery of the Cationic Steroid Antibiotic CSA-90 Enables Osseous Union in a Rat Open Fracture Model of Staphylococcus aureus Infection
Aaron Schindeler et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2015)
Nanomaterial-Based Approaches for Prevention of Biofilm-Associated Infections on Medical Devices and Implants
Kshipra Naik et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2015)
Antibacterial activity of magnetic iron oxide nanoparticles synthesized by laser ablation in liquid
Raid A. Ismail et al.
Materials Science & Engineering C-Materials for Biological Applications (2015)
Size dependent biodistribution and toxicokinetics of iron oxide magnetic nanoparticles in mice
Lin Yang et al.
NANOSCALE (2015)
Fighting microbial infections: A lesson from amphibian skin-derived esculentin-1 peptides
Maria Luisa Mangoni et al.
PEPTIDES (2015)
Bactericidal activity and biocompatibility of ceragenin-coated magnetic nanoparticles
Katarzyna Niemirowicz et al.
JOURNAL OF NANOBIOTECHNOLOGY (2015)
Effect of silver nanoparticles on Candida albicans biofilms: an ultrastructural study
Humberto H. Lara et al.
JOURNAL OF NANOBIOTECHNOLOGY (2015)
Antitumor Activities of Metal Oxide Nanoparticles
Maria Pilar Vinardell et al.
NANOMATERIALS (2015)
The formyl peptide receptor 1 exerts a tumor suppressor function in human gastric cancer by inhibiting angiogenesis
N. Prevete et al.
ONCOGENE (2015)
The role of the antimicrobial peptide cathelicidin in renal diseases
Milan Chromek
PEDIATRIC NEPHROLOGY (2015)
Ceragenin Mediated Selectivity of Antimicrobial Silver Nanoparticles
Mark A. Hoppens et al.
ACS APPLIED MATERIALS & INTERFACES (2014)
Human cathelicidin LL-37 and its derivative IG-19 regulate interleukin-32-induced inflammation
Ka-Yee G. Choi et al.
IMMUNOLOGY (2014)
Maghemite, silver, ceragenin conjugate particles for selective binding and contrast of bacteria
Mark A. Hoppens et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2014)
Responses of Candida albicans to the Human Antimicrobial Peptide LL-37
Pei-Wen Tsai et al.
JOURNAL OF MICROBIOLOGY (2014)
Size-Dependent Effect of Zinc Oxide on Toxicity and Inflammatory Potential of Human Monocytes
Devashri Sahu et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES (2014)
In Vitro Bactericidal and Bacteriolytic Activity of Ceragenin CSA-13 against Planktonic Cultures and Biofilms of Streptococcus pneumoniae and Other Pathogenic Streptococci
Miriam Moscoso et al.
PLOS ONE (2014)
Treatment with LL-37 is safe and effective in enhancing healing of hard-to-heal venous leg ulcers: a randomized, placebo-controlled clinical trial
Alvar Gronberg et al.
WOUND REPAIR AND REGENERATION (2014)
Physicochemical Properties of Nanomaterials: Implication in Associated Toxic Manifestations
Manzoor Ahmad Gatoo et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Antimicrobial Peptides: Their Role as Infection-Selective Tracers for Molecular Imaging
Thomas Ebenhan et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Antibacterial Efficacy of Iron-Oxide Nanoparticles against Biofilms on Different Biomaterial Surfaces
Monica Thukkaram et al.
INTERNATIONAL JOURNAL OF BIOMATERIALS (2014)
Ceragenins - a new weapon to fight multidrug resistant bacterial infections
Urszula Surel et al.
MEDICAL STUDIES-STUDIA MEDYCZNE (2014)
Role of Size and Shape on Biofilm Eradication for Nitric Oxide-Releasing Silica Nanoparticles
Danielle L. Slomberg et al.
ACS APPLIED MATERIALS & INTERFACES (2013)
Nanotechnology as a therapeutic tool to combat microbial resistance
Robert Y. Pelgrift et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Ceragenin CSA-13 induces cell cycle arrest and antiproliferative effects in wild-type and p53 null mutant HCT116 colon cancer cells
Kengo Kuroda et al.
ANTI-CANCER DRUGS (2013)
Ciprofloxacin Treatment Failure in a Murine Model of Pyelonephritis Due to an AAC(6′)-Ib-cr-Producing Escherichia coli Strain Susceptible to Ciprofloxacin In Vitro
T. Guillard et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Pharmacokinetics of amphotericin B lipid complex in critically ill patients undergoing continuous venovenous haemodiafiltration
Maeve E. Malone et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Identification of O-glycosylated Proteins That Are Aberrantly Excreted in the Urine of Patients with Early Stage Ovarian Cancer
Alan Kang-Wai Mu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Characterization of a novel active release coating to prevent biofilm implant-related infections
Dustin L. Williams et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS (2013)
Platinum-resistance in ovarian cancer cells is mediated by IL-6 secretion via the increased expression of its target cIAP-2
Sharon Cohen et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
FK-16 Derived from the Anticancer Peptide LL-37 Induces Caspase-Independent Apoptosis and Autophagic Cell Death in Colon Cancer Cells
Shun X. Ren et al.
PLOS ONE (2013)
Iron oxide particles modulate the ovalbumin-induced Th2 immune response in mice
Masarin Ban et al.
TOXICOLOGY LETTERS (2013)
Microenvironment mesenchymal cells protect ovarian cancer cell lines from apoptosis by inhibiting XIAP inactivation
M. Castells et al.
CELL DEATH & DISEASE (2013)
Study of the effect of antimicrobial peptide mimic, CSA-13, on an established biofilm formed by Pseudomonas aeruginosa
Carole Nagant et al.
MICROBIOLOGYOPEN (2013)
Immunostimulatory Effects of Silica Nanoparticles in Human Monocytes
Eun-Jeoung Yang et al.
Immune Network (2013)
Optimization of Ceragenins for Prevention of Bacterial Colonization of Hydrogel Contact Lenses
Xiaobo Gu et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2013)
Host Immune Defense Peptide LL-37 Activates Caspase-Independent Apoptosis and Suppresses Colon Cancer
Shun X. Ren et al.
CANCER RESEARCH (2012)
In vitro evaluation of the potential for resistance development to ceragenin CSA-13
Jake E. Pollard et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Natural antimicrobial peptides from bacteria: characteristics and potential applications to fight against antibiotic resistance
M. Hassan et al.
JOURNAL OF APPLIED MICROBIOLOGY (2012)
Altered Expression of Sialylated Glycoproteins in Breast Cancer Using Hydrazide Chemistry and Mass Spectrometry
Yuan Tian et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
An architectural journey: from trees, dendrons/dendrimers to nanomedicine
Hannah Stanwix et al.
NANOMEDICINE (2012)
Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor
A. Girnita et al.
ONCOGENE (2012)
Anti-proliferative effect of an analogue of the LL-37 peptide in the colon cancer derived cell line HCT116 p53+/+ and p53-/-
Kengo Kuroda et al.
ONCOLOGY REPORTS (2012)
Nanoalumina promotes the horizontal transfer of multiresistance genes mediated by plasmids across genera
Zhigang Qiu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Effect of a low concentration of a cationic steroid antibiotic (CSA-13) on the formation of a biofilm by Pseudomonas aeruginosa
C. Nagant et al.
JOURNAL OF APPLIED MICROBIOLOGY (2011)
Nanoantibiotics: A new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era
Ae Jung Huh et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Nanotherapeutics to Overcome Conventional Cancer Chemotherapy Limitations
C. Moorthi et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2011)
Wound healing activity of the human antimicrobial peptide LL37
Reinaldo Ramos et al.
PEPTIDES (2011)
Antifungal action of human cathelicidin fragment (LL13-37) on Candida albicans
Jack Ho Wong et al.
PEPTIDES (2011)
LL-37 as a Therapeutic Target for Late Stage Prostate Cancer
Jonathan A. Hensel et al.
PROSTATE (2011)
Depolarization, Bacterial Membrane Composition, and the Antimicrobial Action of Ceragenins
Raquel F. Epand et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Interaction between tobramycin and CSA-13 on clinical isolates of Pseudomonas aeruginosa in a model of young and mature biofilms
Carole Nagant et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2010)
Cathelicidin LL-37: A Multitask Antimicrobial Peptide
Robert Bucki et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2010)
The antimicrobial peptide human cationic antimicrobial protein-18/cathelicidin LL-37 as a putative growth factor for malignant melanoma
J. E. Kim et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Squalamine, an original chemosensitizer to combat antibiotic-resistant Gram-negative bacteria
Jean-Philippe Lavigne et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Synergistic Interaction between Silver Nanoparticles and Membrane-Permeabilizing Antimicrobial Peptides
Serge Ruden et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
The anticancer activity of lytic peptides is inhibited by heparan sulfate on the surface of the tumor cells
Bodil Fadnes et al.
BMC CANCER (2009)
Bactericidal activities of the cationic steroid CSA-13 and the cathelicidin peptide LL-37 against Helicobacter pylori in simulated gastric juice
Katarzyna Leszczynska et al.
BMC MICROBIOLOGY (2009)
Inhibition of Staphylococcus aureus Biofilms by a Novel Antibacterial Envelope for Use with Implantable Cardiac Devices
Alessandra Agostinho et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2009)
Treatment with LL-37 Peptide Enhances Antitumor Effects Induced by CpG Oligodeoxynucleotides Against Ovarian Cancer
Chi-Mu Chuang et al.
HUMAN GENE THERAPY (2009)
The Human Host Defense Peptide LL-37 Induces Apoptosis in a Calpain- and Apoptosis-Inducing Factor-Dependent Manner Involving Bax Activity
Jamie S. Mader et al.
MOLECULAR CANCER RESEARCH (2009)
The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells
Seth B. Coffelt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Ceragenin CSA-13 exhibits antimicrobial activity against cariogenic and periodontopathic bacteria
E. Isogai et al.
ORAL MICROBIOLOGY AND IMMUNOLOGY (2009)
Ceragenins: Cholic Acid-Based Mimics of Antimicrobial Peptides
Xin-Zhong Lai et al.
ACCOUNTS OF CHEMICAL RESEARCH (2008)
Mannose-targeted systems for the delivery of therapeutics
Juan M. Irache et al.
EXPERT OPINION ON DRUG DELIVERY (2008)
Salivary mucins inhibit antibacterial activity of the cathelicidin-derived LL-37 peptide but not the cationic steroid CSA-13
Robert Bucki et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Enhancement of the efficacy of erythromycin in multiple antibiotic-resistant gram-negative bacterial pathogens
S. Saha et al.
JOURNAL OF APPLIED MICROBIOLOGY (2008)
Brevinin-2R1 semi-selectively kills cancer cells by a distinct mechanism, which involves the lysosomal-mitochondrial death pathway
Saeid Ghavami et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells
Judith von Haussen et al.
LUNG CANCER (2008)
Ovarian cancers overexpress the antimicrobial protein hCAP-18 and its derivative LL-37 increases ovarian cancer cell proliferation and invasion
Seth B. Coffelt et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Resistance of the antibacterial agent ceragenin CSA-13 to inactivation by DNA or F-actin and its activity in cystic fibrosis sputum
Robert Bucki et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Immunological properties of engineered nanomaterials
Marina A. Dobrovolskaia et al.
NATURE NANOTECHNOLOGY (2007)
Nanoparticle interaction with biological membranes: Does nanotechnology present a janus face?
Pascale R. Leroueil et al.
ACCOUNTS OF CHEMICAL RESEARCH (2007)
Antimicrobial activities of ceragenins against clinical isolates of resistant Staphylococcus aureus
Judy N. Chin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Susceptibility of periodontopathogenic and cariogenic bacteria to Defensins and potential therapeutic use of Defensins in oral diseases
Hitoshi Komatsuzawa et al.
CURRENT PHARMACEUTICAL DESIGN (2007)
Bovine and human cathelicidin cationic host defense peptides similarly suppress transcriptional responses to bacterial lipopolysaccharide
Neeloffer Mookherjee et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
Robert E. W. Hancock et al.
NATURE BIOTECHNOLOGY (2006)
Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region
X Li et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37
N Mookherjee et al.
JOURNAL OF IMMUNOLOGY (2006)
Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides - Peptide properties and plausible modes of action
Y Rosenfeld et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
LL-37, the only human member of the cathelicidin family of antimicrobial peptides
Ulrich H. N. Durr et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2006)
Antimicrobial protein hCAP18/LL-37 is highly expressed in breast cancer and is a putative growth factor for epithelial cells
JD Heilborn et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Marked reduction of LL-37/hCAP-18, an antimicrobial peptide, in patients with acute myeloid leukemia
LL An et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2005)
A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1β processing and release
A Elssner et al.
JOURNAL OF IMMUNOLOGY (2004)
Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases
M Sieprawska-Lupa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Origins of cell selectivity of cationic steroid antibiotics
BW Ding et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2004)
Endogenous antimicrobial peptides and skin infections in atopic dermatitis
PY Ong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses
MG Scott et al.
JOURNAL OF IMMUNOLOGY (2002)
Cell membrane fluidity and prognosis of lung cancer
M Sok et al.
ANNALS OF THORACIC SURGERY (2002)
BMAP-28, an antibiotic peptide of innate immunity, induces cell death through opening of the mitochondrial permeability transition pore
A Risso et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-α by blocking the binding of LPS to CD14+ cells
I Nagaoka et al.
JOURNAL OF IMMUNOLOGY (2001)
分享论文
